A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
As the American population grows ever more diverse, cancer researchers are discovering that digging deep into demographic information can...
Last month, federal agencies approved changes to the Common Rule, which regulates the way federally funded biomedical research is...
The fact that there are differences in screening mammography recommendations highlights the need for additional research into the benefits...
Chemical probes are small, drug-like molecules that are useful in interrogating biology in disease models. In order for a...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...
Guest Post by Jenine Sanzari, PhD Stand Up To Cancer recently held its seventh annual Scientific Summit, organized by...
Saturday, February 4, is World Cancer Day, an initiative of the Union for International Cancer Control (UICC).
Cancer Today and the AACR are hosting a webinar on Feb. 16 at 1 p.m. EST. A panel of...
Patients have long benefited from combination treatments—whether combining surgery with chemotherapy and radiation, or combining chemotherapy agents in succession.
The FDA has approved expanding the use of the molecularly targeted therapeutic ibrutinib (Imbruvica) to include the treatment of...